Eva Schrezenmeier
Impact in
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
- Nephrology top 2%
- Acute Kidney Injury Research
Papers in
-
- Renal Transplantation Outcomes and Treatments 29
- Nephrology 12
- Renal Diseases and Glomerulopathies 8
- Co-authors
- Thomas DörnerKlemens BuddeKai M. Schmidt‐OttTimm H. WesthoffJonathan BaraschFabian HalleckAna‐Luisa StefanskiAndreia C. Lino
In The Last Decade
Eva Schrezenmeier
70 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Transplantation 278
- Nephrology 328
- Infectious Diseases 628
- Rheumatology 301
- Immunology 419
Countries citing papers authored by Eva Schrezenmeier
This map shows the geographic impact of Eva Schrezenmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Schrezenmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Schrezenmeier more than expected).
Fields of papers citing papers by Eva Schrezenmeier
This network shows the impact of papers produced by Eva Schrezenmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Schrezenmeier. The network helps show where Eva Schrezenmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Schrezenmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 61 | |
| 12 | 2021 | 35 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 3 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 11 | |
| 17 | 2019 | 7 | |
| 18 | 2017 | 3 | |
| 19 | 2017 | 7 | |
| 20 | 2016 | 22 |
About Eva Schrezenmeier
Eva Schrezenmeier is a scholar working on Transplantation, Nephrology, Immunology, Infectious Diseases and Rheumatology, having authored 78 papers that have together received 2.2k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (29 papers), SARS-CoV-2 and COVID-19 Research (17 papers), COVID-19 Clinical Research Studies (13 papers), T-cell and B-cell Immunology (10 papers), Systemic Lupus Erythematosus Research (10 papers), Renal Diseases and Glomerulopathies (8 papers), Immune Cell Function and Interaction (7 papers) and Neurological Complications and Syndromes (7 papers). The work is most often cited by research in Transplantation (278 citations), Nephrology (328 citations), Infectious Diseases (628 citations), Rheumatology (301 citations) and Immunology (419 citations). Eva Schrezenmeier has collaborated with scholars based in Germany, Colombia and Austria. Frequent co-authors include Thomas Dörner, Klemens Budde, Kai M. Schmidt‐Ott, Timm H. Westhoff, Jonathan Barasch, Fabian Halleck, Ana‐Luisa Stefanski, Andreia C. Lino, Bilgin Osmanodja and Kai‐Uwe Eckardt. Their work appears in journals such as Frontiers in Immunology, Nephrology Dialysis Transplantation, Journal of Clinical Medicine, Transplant International and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.